Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia

Eur J Clin Microbiol Infect Dis. 2001 Jan;20(1):73-5. doi: 10.1007/pl00011239.

Authors

M F Tripodi¹, A Andreana, G Sarnataro, E Ragone, L E Adinolfi, R Utili

Affiliation

¹ Institute of Medical Therapy, Faculty of Medicine, Second University of Naples, Italy. MarieFranc.Tripodi@unina2.it

PMID: 11245333
DOI: 10.1007/pl00011239

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Amikacin / pharmacology
Amikacin / therapeutic use
Anti-Bacterial Agents / pharmacology*
Anti-Bacterial Agents / therapeutic use
Anti-Infective Agents / pharmacology*
Anti-Infective Agents / therapeutic use
Cefepime
Cephalosporins / pharmacology
Cephalosporins / therapeutic use
Ciprofloxacin / pharmacology
Ciprofloxacin / therapeutic use
Colony Count, Microbial
Drug Resistance, Bacterial
Drug Resistance, Multiple, Bacterial
Drug Synergism
Drug Therapy, Combination
Gentamicins / pharmacology
Gentamicins / therapeutic use
Gram-Negative Bacterial Infections / drug therapy*
Gram-Negative Bacterial Infections / microbiology
Microbial Sensitivity Tests
Stenotrophomonas maltophilia / drug effects*
Time Factors

Substances

Anti-Bacterial Agents
Anti-Infective Agents
Cephalosporins
Gentamicins
Ciprofloxacin
Cefepime
Amikacin
isepamicin